{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "35477769", "DateCompleted": {"Year": "2022", "Month": "11", "Day": "16"}, "DateRevised": {"Year": "2023", "Month": "02", "Day": "02"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "04", "Day": "27"}], "Language": ["eng"], "ELocationID": ["10.1038/s41417-022-00471-4"], "Journal": {"ISSN": "1476-5500", "JournalIssue": {"Volume": "29", "Issue": "11", "PubDate": {"Year": "2022", "Month": "Nov"}}, "Title": "Cancer gene therapy", "ISOAbbreviation": "Cancer Gene Ther"}, "ArticleTitle": "A critical ETV4/Twist1/Vimentin axis in Ha-RAS-induced aggressive breast cancer.", "Pagination": {"StartPage": "1590", "EndPage": "1599", "MedlinePgn": "1590-1599"}, "Abstract": {"AbstractText": ["RAS oncogenes are major drivers of diverse types of cancer. However, they are largely not druggable, and therefore targeting critical downstream pathways and dependencies is an attractive approach. We have isolated a tumorigenic cell line (FE1.2), which exhibits mesenchymal characteristics, after inoculating Ha-Ras-expressing retrovirus into mammary glands of rats, and subsequently isolated a non-aggressive revertant cell line (FC5). This revertant has lost the rat Ha-Ras driver and showed a more epithelial morphology, slower proliferation in culture, and reduced tumorigenicity in vivo. Re-expression of human Ha-RAS in these cells (FC5-RAS) reinduced mesenchymal morphology, higher proliferation rate, and tumorigenicity that was still significantly milder than parental FE1.2 cells. RNA-seq analysis of FC5-RAS vs FC5-Vector cells identified multiple genes whose expressions were regulated by Ha-RAS. This analysis also identified many genes including those controlling cell growth whose expression was altered by loss of HA-Ras in FC5 cells but remained unchanged upon reintroduction of Ha-RAS. These results suggest that targeting the Ha-Ras driver oncogene induces partial tumor regression, but it still denotes strong efficacy for cancer therapy. Among the RAS-responsive genes, we identified Twist1 as a critical mediator of epithelial-to-mesenchymal transition through the direct transcriptional regulation of vimentin. Mechanistically, we show that Twist1 is induced by the ETS gene, ETV4, downstream of Ha-RAS, and that inhibition of ETV4 suppressed the growth of breast cancer cells driven by the Ha-RAS pathway. Targeting the ETV4/Twist1/Vimentin axis may therefore offer a therapeutic modality for breast tumors driven by the Ha-RAS pathway."], "CopyrightInformation": "\u00a9 2022. The Author(s), under exclusive licence to Springer Nature America, Inc."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory for Functions and Applications of Medicinal Plants/College of Basic Medical Sciences, Guizhou Medical University, Guiyang, Guizhou, China."}, {"Identifier": [], "Affiliation": "The Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academic of Sciences, Guiyang, Guizhou, China."}], "LastName": "Liu", "ForeName": "Wuling", "Initials": "W"}, {"Identifier": ["0000-0001-5764-581X"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory for Functions and Applications of Medicinal Plants/College of Basic Medical Sciences, Guizhou Medical University, Guiyang, Guizhou, China."}, {"Identifier": [], "Affiliation": "The Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academic of Sciences, Guiyang, Guizhou, China."}, {"Identifier": [], "Affiliation": "School of Pharmaceutical Sciences, Guizhou Medical University, Guiyang, Guizhou, China."}], "LastName": "Gajendran", "ForeName": "Babu", "Initials": "B"}, {"Identifier": ["0000-0003-1555-4009"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory for Functions and Applications of Medicinal Plants/College of Basic Medical Sciences, Guizhou Medical University, Guiyang, Guizhou, China."}, {"Identifier": [], "Affiliation": "The Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academic of Sciences, Guiyang, Guizhou, China."}], "LastName": "Sample", "ForeName": "Klarke M", "Initials": "KM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory for Functions and Applications of Medicinal Plants/College of Basic Medical Sciences, Guizhou Medical University, Guiyang, Guizhou, China."}, {"Identifier": [], "Affiliation": "The Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academic of Sciences, Guiyang, Guizhou, China."}], "LastName": "Wang", "ForeName": "Chunlin", "Initials": "C"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory for Functions and Applications of Medicinal Plants/College of Basic Medical Sciences, Guizhou Medical University, Guiyang, Guizhou, China."}, {"Identifier": [], "Affiliation": "The Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academic of Sciences, Guiyang, Guizhou, China."}], "LastName": "Hu", "ForeName": "Anling", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory for Functions and Applications of Medicinal Plants/College of Basic Medical Sciences, Guizhou Medical University, Guiyang, Guizhou, China."}, {"Identifier": [], "Affiliation": "The Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academic of Sciences, Guiyang, Guizhou, China."}], "LastName": "Chen", "ForeName": "Beiling", "Initials": "B"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory for Functions and Applications of Medicinal Plants/College of Basic Medical Sciences, Guizhou Medical University, Guiyang, Guizhou, China."}, {"Identifier": [], "Affiliation": "The Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academic of Sciences, Guiyang, Guizhou, China."}], "LastName": "Li", "ForeName": "Yanmei", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medicine, University of Toronto, Toronto, ON, Canada."}, {"Identifier": [], "Affiliation": "Division of Advanced Diagnostics, Toronto General Research Institute-University Health Network, Toronto, ON, Canada."}], "LastName": "Zacksenhaus", "ForeName": "Eldad", "Initials": "E"}, {"Identifier": ["0000-0002-9020-6074"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory for Functions and Applications of Medicinal Plants/College of Basic Medical Sciences, Guizhou Medical University, Guiyang, Guizhou, China. yaacovbendavid@gzcnp.cn."}, {"Identifier": [], "Affiliation": "The Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academic of Sciences, Guiyang, Guizhou, China. yaacovbendavid@gzcnp.cn."}], "LastName": "Ben-David", "ForeName": "Yaacov", "Initials": "Y"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Cancer Gene Ther", "NlmUniqueID": "9432230", "ISSNLinking": "0929-1903"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Vimentin"}, {"RegistryNumber": "0", "NameOfSubstance": "TWIST1 protein, human"}, {"RegistryNumber": "0", "NameOfSubstance": "Nuclear Proteins"}, {"RegistryNumber": "0", "NameOfSubstance": "Twist-Related Protein 1"}, {"RegistryNumber": "0", "NameOfSubstance": "ETV4 protein, human"}, {"RegistryNumber": "0", "NameOfSubstance": "Proto-Oncogene Proteins c-ets"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Rats"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": ["genetics", "pathology"], "DescriptorName": "Breast Neoplasms"}, {"QualifierName": ["genetics"], "DescriptorName": "Vimentin"}, {"QualifierName": [], "DescriptorName": "Genes, ras"}, {"QualifierName": ["genetics"], "DescriptorName": "Carcinogenesis"}, {"QualifierName": ["genetics"], "DescriptorName": "Cell Proliferation"}, {"QualifierName": ["genetics"], "DescriptorName": "Cell Transformation, Neoplastic"}, {"QualifierName": ["genetics"], "DescriptorName": "Nuclear Proteins"}, {"QualifierName": ["genetics"], "DescriptorName": "Twist-Related Protein 1"}, {"QualifierName": ["genetics"], "DescriptorName": "Proto-Oncogene Proteins c-ets"}]}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209\u201349.", "ArticleIdList": ["33538338", "10.3322/caac.21660"]}, {"Citation": "Zacksenhaus E, Liu JC, Jiang Z, Yao Y, Xia L, Shrestha M, et al. Transcription factors in breast cancer-lessons from recent genomic analyses and therapeutic implications. Adv Protein Chem Struct Biol. 2017;107:223\u201373.", "ArticleIdList": ["28215225", "10.1016/bs.apcsb.2016.10.003"]}, {"Citation": "Drilon A, Hu ZI, Lai GGY, Tan DSW. Targeting RET-driven cancers: lessons from evolving preclinical and clinical landscapes. Nat Rev Clin Oncol. 2018;15:150.", "ArticleIdList": ["29182164", "10.1038/nrclinonc.2017.188"]}, {"Citation": "Guo Y, Cao R, Zhang X, Huang L, Sun L, Zhao J, et al. Recent progress in rare oncogenic drivers and targeted therapy for non-small cell lung cancer. Onco Targets Ther. 2019;12:10343\u201360.", "ArticleIdList": ["31819518", "6886531", "10.2147/OTT.S230309"]}, {"Citation": "Siena S, Sartore-Bianchi A, Marsoni S, Hurwitz HI, McCall SJ, Penault-Llorca F, et al. Targeting the human epidermal growth factor receptor 2 (HER2) oncogene in colorectal cancer. Ann Oncol. 2018;29:1108\u201319.", "ArticleIdList": ["29659677", "5961091", "10.1093/annonc/mdy100"]}, {"Citation": "Meng D, Carvajal RD. KIT as an oncogenic driver in melanoma: an update on clinical development. Am J Clin Dermatol. 2019;20:315\u201323.", "ArticleIdList": ["30707374", "10.1007/s40257-018-0414-1"]}, {"Citation": "Roman M, Baraibar I, Lopez I, Nadal E, Rolfo C, Vicent S, et al. KRAS oncogene in non-small cell lung cancer: clinical perspectives on the treatment of an old target. Mol Cancer. 2018;17:33.", "ArticleIdList": ["29455666", "5817724", "10.1186/s12943-018-0789-x"]}, {"Citation": "Takashima A, Faller DV. Targeting the RAS oncogene. Expert Opin Ther Targets. 2013;17:507\u201331.", "ArticleIdList": ["23360111", "3804031", "10.1517/14728222.2013.764990"]}, {"Citation": "Holderfield M, Deuker MM, McCormick F, McMahon M. Targeting RAF kinases for cancer therapy: BRAF-mutated melanoma and beyond. Nat Rev Cancer. 2014;14:455\u201367.", "ArticleIdList": ["24957944", "4250230", "10.1038/nrc3760"]}, {"Citation": "Dankner M, Rose AAN, Rajkumar S, Siegel PM, Watson IR. Classifying BRAF alterations in cancer: new rational therapeutic strategies for actionable mutations. Oncogene. 2018;37:3183\u201399.", "ArticleIdList": ["29540830", "10.1038/s41388-018-0171-x"]}, {"Citation": "Samatar AA, Poulikakos PI. Targeting RAS-ERK signalling in cancer: promises and challenges. Nat Rev Drug Discov. 2014;13:928\u201342.", "ArticleIdList": ["25435214", "10.1038/nrd4281"]}, {"Citation": "Felipe Lima J, Nofech-Mozes S, Bayani J, Bartlett JM. EMT in breast carcinoma\u2014a review. J Clin Med. 2016;5:65."}, {"Citation": "Vuoriluoto K, Haugen H, Kiviluoto S, Mpindi JP, Nevo J, Gjerdrum C, et al. Vimentin regulates EMT induction by Slug and oncogenic H-Ras and migration by governing Axl expression in breast cancer. Oncogene. 2011;30:1436\u201348.", "ArticleIdList": ["21057535", "10.1038/onc.2010.509"]}, {"Citation": "Khan MA, Chen HC, Zhang D, Fu J. Twist: a molecular target in cancer therapeutics. Tumour Biol. 2013;34:2497\u2013506.", "ArticleIdList": ["23873099", "10.1007/s13277-013-1002-x"]}, {"Citation": "Li YJ, Song R, Korkola JE, Archer MC, Ben-David Y. Cyclin D1 is necessary but not sufficient for anchorage-independent growth of rat mammary tumor cells and is associated with resistance of the Copenhagen rat to mammary carcinogenesis. Oncogene. 2003;22:3452\u201362.", "ArticleIdList": ["12776197", "10.1038/sj.onc.1206411"]}, {"Citation": "M\u00fcller M, Beck IM, Gadesmann J, Karschuk N, Paschen A, Proksch E, et al. MMP19 is upregulated during melanoma progression and increases invasion of melanoma cells. Mod Pathol. 2010;23:511\u201321.", "ArticleIdList": ["20098411", "10.1038/modpathol.2009.183"]}, {"Citation": "Meng Y, Wang L, Chen D, Chang Y, Zhang M, Xu JJ, et al. LAPTM4B: an oncogene in various solid tumors and its functions. Oncogene. 2016;35:6359\u201365.", "ArticleIdList": ["27212036", "5161753", "10.1038/onc.2016.189"]}, {"Citation": "Zhong FJ, Sun B, Cao MM, Xu C, Li YM, Yang LY. STMN2 mediates nuclear translocation of Smad2/3 and enhances TGFbeta signaling by destabilizing microtubules to promote epithelial-mesenchymal transition in hepatocellular carcinoma. Cancer Lett. 2021;506:128\u201341.", "ArticleIdList": ["33705863", "10.1016/j.canlet.2021.03.001"]}, {"Citation": "Sugimoto M, Kohashi K, Itsumi M, Shiota M, Abe T, Yamada Y, et al. Epithelial to mesenchymal transition in clear cell renal cell carcinoma with rhabdoid features. Pathobiology. 2016;83:277\u201386.", "ArticleIdList": ["27225469", "10.1159/000445752"]}, {"Citation": "Taube JH, Herschkowitz JI, Komurov K, Zhou AY, Gupta S, Yang J, et al. Core epithelial-to-mesenchymal transition interactome gene-expression signature is associated with claudin-low and metaplastic breast cancer subtypes. Proc Natl Acad Sci USA. 2010;107:15449\u201354.", "ArticleIdList": ["20713713", "2932589", "10.1073/pnas.1004900107"]}, {"Citation": "Meng J, Chen S, Han JX, Qian B, Wang XR, Zhong WL, et al. Twist1 regulates vimentin through Cul2 circular RNA to promote EMT in hepatocellular carcinoma. Cancer Res. 2018;78:4150\u201362.", "ArticleIdList": ["29844124", "10.1158/0008-5472.CAN-17-3009"]}, {"Citation": "Baker R, Kent CV, Silbermann RA, Hassell JA, Young LJ, Howe LR. Pea3 transcription factors and wnt1-induced mouse mammary neoplasia. PLoS ONE. 2010;5:e8854.", "ArticleIdList": ["20107508", "2809747", "10.1371/journal.pone.0008854"]}, {"Citation": "Liu CY, Yu T, Huang Y, Cui L, Hong W. ETS (E26 transformation-specific) up-regulation of the transcriptional co-activator TAZ promotes cell migration and metastasis in prostate cancer. J Biol Chem. 2017;292:9420\u201330.", "ArticleIdList": ["28408625", "5454120", "10.1074/jbc.M117.783787"]}, {"Citation": "Eckert LB, Repasky GA, Ulku AS, McFall A, Zhou H, Sartor CI, et al. Involvement of Ras activation in human breast cancer cell signaling, invasion, and anoikis. Cancer Res. 2004;64:4585\u201392.", "ArticleIdList": ["15231670", "10.1158/0008-5472.CAN-04-0396"]}, {"Citation": "Prior IA, Lewis PD, Mattos C. A comprehensive survey of Ras mutations in cancer. Cancer Res. 2012;72:2457\u201367.", "ArticleIdList": ["22589270", "3354961", "10.1158/0008-5472.CAN-11-2612"]}, {"Citation": "Klock G, Storch S, Rickert J, Gutacker C, Koch-Brandt C. Differential regulation of the clusterin gene by Ha-ras and c-myc oncogenes and during apoptosis. J Cell Physiol. 1998;177:593\u2013605.", "ArticleIdList": ["10092212", "10.1002/(SICI)1097-4652(199812)177:4<593::AID-JCP10>3.0.CO;2-F"]}, {"Citation": "Zhang D, Sun B, Zhao X, Cui Y, Xu S, Dong X, et al. Secreted CLU is associated with the initiation of triple-negative breast cancer. Cancer Biol Ther. 2012;13:321\u20139.", "ArticleIdList": ["22310975", "10.4161/cbt.19072"]}, {"Citation": "Loomans HA, Andl CD. Intertwining of activin A and TGFbeta signaling: dual roles in cancer progression and cancer cell invasion. Cancers (Basel). 2014;7:70\u201391.", "ArticleIdList": ["10.3390/cancers7010070"]}, {"Citation": "Benatar T, Yang W, Amemiya Y, Evdokimova V, Kahn H, Holloway C, et al. IGFBP7 reduces breast tumor growth by induction of senescence and apoptosis pathways. Breast Cancer Res Treat. 2012;133:563\u201373.", "ArticleIdList": ["21997538", "10.1007/s10549-011-1816-4"]}, {"Citation": "Chang Y, Zuka M, Perez-Pinera P, Astudillo A, Mortimer J, Berenson JR, et al. Secretion of pleiotrophin stimulates breast cancer progression through remodeling of the tumor microenvironment. Proc Natl Acad Sci USA. 2007;104:10888\u201393.", "ArticleIdList": ["17578909", "1904160", "10.1073/pnas.0704366104"]}, {"Citation": "Li Q, Zhu CC, Ni B, Zhang ZZ, Jiang SH, Hu LP, et al. Lysyl oxidase promotes liver metastasis of gastric cancer via facilitating the reciprocal interactions between tumor cells and cancer associated fibroblasts. EBioMedicine. 2019;49:157\u201371.", "ArticleIdList": ["31678002", "7113184", "10.1016/j.ebiom.2019.10.037"]}, {"Citation": "Luo XG, Zhang CL, Zhao WW, Liu ZP, Liu L, Mu A, et al. Histone methyltransferase SMYD3 promotes MRTF-A-mediated transactivation of MYL9 and migration of MCF-7 breast cancer cells. Cancer Lett. 2014;344:129\u201337.", "ArticleIdList": ["24189459", "10.1016/j.canlet.2013.10.026"]}, {"Citation": "Yang B, Huang J, Xiang T, Yin X, Luo X, Huang J, et al. Chrysin inhibits metastatic potential of human triple-negative breast cancer cells by modulating matrix metalloproteinase-10, epithelial to mesenchymal transition, and PI3K/Akt signaling pathway. J Appl Toxicol. 2014;34:105\u201312.", "ArticleIdList": ["24122885", "10.1002/jat.2941"]}, {"Citation": "Margheri F, Serrati S, Lapucci A, Anastasia C, Giusti B, Pucci M, et al. Systemic sclerosis-endothelial cell antiangiogenic pentraxin 3 and matrix metalloprotease 12 control human breast cancer tumor vascularization and development in mice. Neoplasia. 2009;11:1106\u201315.", "ArticleIdList": ["19794969", "2745676", "10.1593/neo.09934"]}, {"Citation": "Ye T, Liang Y, Zhang D, Zhang X. MicroRNA-16-1-3p represses breast tumor growth and metastasis by inhibiting PGK1-mediated Warburg effect. Front Cell Dev Biol. 2020;8:615154.", "ArticleIdList": ["33344462", "7744604", "10.3389/fcell.2020.615154"]}, {"Citation": "Chen X, Zhao M, Huang J, Li Y, Wang S, Harrington CA, et al. microRNA-130a suppresses breast cancer cell migration and invasion by targeting FOSL1 and upregulating ZO-1. J Cell Biochem. 2018;119:4945\u201356.", "ArticleIdList": ["29384218", "10.1002/jcb.26739"]}, {"Citation": "Wei M, Yu H, Cai C, Gao R, Liu X, Zhu H. MiR-3194-3p inhibits breast cancer progression by targeting Aquaporin1. Front Oncol. 2020;10:1513.", "ArticleIdList": ["32903818", "7438898", "10.3389/fonc.2020.01513"]}, {"Citation": "Yu G, Herazo-Maya JD, Nukui T, Romkes M, Parwani A, Juan-Guardela BM, et al. Matrix metalloproteinase-19 promotes metastatic behavior in vitro and is associated with increased mortality in non-small cell lung cancer. Am J Respir Crit Care Med. 2014;190:780\u201390.", "ArticleIdList": ["25250855", "4299607", "10.1164/rccm.201310-1903OC"]}, {"Citation": "Li Y, Zou L, Li Q, Haibe-Kains B, Tian R, Li Y, et al. Amplification of LAPTM4B and YWHAZ contributes to chemotherapy resistance and recurrence of breast cancer. Nat Med. 2010;16:214\u20138.", "ArticleIdList": ["20098429", "2826790", "10.1038/nm.2090"]}, {"Citation": "Barsyte-Lovejoy D, Lau SK, Boutros PC, Khosravi F, Jurisica I, Andrulis IL, et al. The c-Myc oncogene directly induces the H19 noncoding RNA by allele-specific binding to potentiate tumorigenesis. Cancer Res. 2006;66:5330\u20137.", "ArticleIdList": ["16707459", "10.1158/0008-5472.CAN-06-0037"]}, {"Citation": "Huang C, Ye Z, Wan J, Liang J, Liu M, Xu X, et al. Secreted frizzled-related protein 2 is associated with disease progression and poor prognosis in breast cancer. Dis Markers. 2019;2019:6149381.", "ArticleIdList": ["30944668", "6421737", "10.1155/2019/6149381"]}, {"Citation": "Xu XL, Yu J, Zhang HY, Sun MH, Gu J, Du X, et al. Methylation profile of the promoter CpG islands of 31 genes that may contribute to colorectal carcinogenesis. World J Gastroenterol. 2004;10:3441\u201354.", "ArticleIdList": ["15526363", "4576225", "10.3748/wjg.v10.i23.3441"]}, {"Citation": "Narayanaswamy PB, Baral TK, Haller H, Dumler I, Acharya K, Kiyan Y. Transcriptomic pathway analysis of urokinase receptor silenced breast cancer cells: a microarray study. Oncotarget. 2017;8:101572\u201390.", "ArticleIdList": ["29254187", "5731897", "10.18632/oncotarget.21351"]}, {"Citation": "Kim MS, Lee WS, Jin W. TrkB promotes breast cancer metastasis via suppression of Runx3 and Keap1 expression. Mol Cells. 2016;39:258\u201365.", "ArticleIdList": ["26657794", "10.14348/molcells.2016.2310"]}, {"Citation": "Boo LM, Lin HH, Chung V, Zhou B, Louie SG, O\u2019Reilly MA, et al. High mobility group A2 potentiates genotoxic stress in part through the modulation of basal and DNA damage-dependent phosphatidylinositol 3-kinase-related protein kinase activation. Cancer Res. 2005;65:6622\u201330.", "ArticleIdList": ["16061642", "10.1158/0008-5472.CAN-05-0086"]}, {"Citation": "Ghafouri-Fard S, Esmaeili M, Taheri M. H19 lncRNA: roles in tumorigenesis. Biomed Pharmacother. 2020;123:109774.", "ArticleIdList": ["31855739", "10.1016/j.biopha.2019.109774"]}, {"Citation": "Zhou T, Lin W, Zhu Q, Renaud H, Liu X, Li R, et al. The role of PEG3 in the occurrence and prognosis of colon cancer. Onco Targets Ther. 2019;12:6001\u201312.", "ArticleIdList": ["31413595", "6662866", "10.2147/OTT.S208060"]}, {"Citation": "Baines KJ, Rampersaud AM, Hillier DM, Jeyarajah MJ, Grafham GK, Eastabrook G, et al. Antiviral inflammation during early pregnancy reduces placental and fetal growth trajectories. J Immunol. 2020;204:694\u2013706.", "ArticleIdList": ["31882516", "10.4049/jimmunol.1900888"]}, {"Citation": "Chaffer CL, San Juan BP, Lim E, Weinberg RA. EMT, cell plasticity and metastasis. Cancer Metastasis Rev. 2016;35:645\u201354.", "ArticleIdList": ["27878502", "10.1007/s10555-016-9648-7"]}, {"Citation": "Yang J, Mani SA, Donaher JL, Ramaswamy S, Itzykson RA, Come C, et al. Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell. 2004;117:927\u201339.", "ArticleIdList": ["15210113", "10.1016/j.cell.2004.06.006"]}, {"Citation": "de Launoit Y, Chotteau-Lelievre A, Beaudoin C, Coutte L, Netzer S, Brenner C, et al. The PEA3 group of ETS-related transcription factors. Role in breast cancer metastasis. Adv Exp Med Biol. 2000;480:107\u201316.", "ArticleIdList": ["10959416", "10.1007/0-306-46832-8_13"]}, {"Citation": "Xia L, Xiao X, Liu WL, Song Y, Liu TJJ, Li YJ, et al. Coactosin-like protein CLP/Cotl1 suppresses breast cancer growth through activation of IL-24/PERP and inhibition of non-canonical TGFbeta signaling. Oncogene. 2018;37:323\u201331.", "ArticleIdList": ["28925397", "10.1038/onc.2017.342"]}, {"Citation": "Song J, Yuan C, Yang J, Liu T, Yao Y, Xiao X, et al. Novel flavagline-like compounds with potent Fli-1 inhibitory activity suppress diverse types of leukemia. FEBS J. 2018;285:4631\u201345.", "ArticleIdList": ["30387554", "10.1111/febs.14690"]}, {"Citation": "Haeri M, Li Y, Li Y, Li Q, Spaner DE, Ben-David Y. Insertional activation of myb by F-MuLV in SCID mice induces myeloid leukemia. Int J Oncol. 2013;43:169\u201376.", "ArticleIdList": ["23677281", "10.3892/ijo.2013.1943"]}, {"Citation": "Liu T, Xia L, Yao Y, Yan C, Fan Y, Gajendran B, et al. Identification of diterpenoid compounds that interfere with Fli-1 DNA binding to suppress leukemogenesis. Cell Death Dis. 2019;10:117.", "ArticleIdList": ["30741932", "6370842", "10.1038/s41419-019-1363-1"]}, {"Citation": "Li YJ, Zhao X, Vecchiarelli-Federico LM, Li Y, Datti A, Cheng Y, et al. Drug-mediated inhibition of Fli-1 for the treatment of leukemia. Blood Cancer J. 2012;2:e54.", "ArticleIdList": ["22829238", "3270256", "10.1038/bcj.2011.52"]}, {"Citation": "Wang C, Song J, Liu W, Yao Y, Kapranov P, Sample KM, et al. FLI1 promotes protein translation via the transcriptional regulation of MKNK1 expression. Int J Oncol. 2020;56:430\u20138.", "ArticleIdList": ["31894299"]}, {"Citation": "Rodriguez-Viciana P, Warne PH, Khwaja A, Marte BM, Pappin D, Das P, et al. Role of phosphoinositide 3-OH kinase in cell transformation and control of the actin cytoskeleton by Ras. Cell. 1997;89:457\u201367.", "ArticleIdList": ["9150145", "10.1016/S0092-8674(00)80226-3"]}], "ReferenceList": []}], "History": [{"Year": "2021", "Month": "11", "Day": "14"}, {"Year": "2022", "Month": "4", "Day": "7"}, {"Year": "2022", "Month": "3", "Day": "29"}, {"Year": "2022", "Month": "4", "Day": "29", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "11", "Day": "18", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "4", "Day": "28", "Hour": "5", "Minute": "28"}], "PublicationStatus": "ppublish", "ArticleIdList": ["35477769", "10.1038/s41417-022-00471-4", "10.1038/s41417-022-00471-4"]}}], "PubmedBookArticle": []}